Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
April 2, 2018
Aeglea BioTherapeutics Doses First Small Cell Lung Cancer Patients with Pegzilarginase in Both Monotherapy and KEYTRUDA® (Pembrolizumab) Combination Trials
AUSTIN, Texas, April 02, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
April 2, 2018
Data Highlighting Advaxis’ ADXS-PSA Accepted as Poster Presentation at the American Society of Clinical Oncology Annual Meeting
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, announces that The American Society of Clinical ...
March 28, 2018
TRACON Pharmaceuticals Announces $38.7 Million Private Placement
SAN DIEGO, March 23, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
March 28, 2018
Kiadis Pharma on track with European regulatory review for ATIR101
Amsterdam, The Netherlands, March 28, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing ...
March 28, 2018
BrainStorm Cell Therapeutics' Phase 3 Trial of NurOwn® in ALS Now Open to Canadian Patients
NEW YORK and PETACH TIKVAH, Israel, March 28, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapeutics for ...
March 28, 2018
Arrowhead Pharmaceuticals Announces Multiple Presentations at The International Liver Congress™
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it will present clinical and pre-clinical data on the company’s investigational medicines for the treatment of ...
March 28, 2018
Paratek Pharmaceuticals to Present at the H.C. Wainwright Annual Global Life Sciences Conference
BOSTON, March 28, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK) today announced that President, Chief Operating Officer and Chief Medical Officer, Evan Loh, MD ...
March 28, 2018
BIOPHYTIS: 2017 Full Year Results
PARIS, March 28, 2018 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris:ALBPS), a biotechnology company specializing in the development of drug candidates for the treatment of ...
March 28, 2018
Aptose Biosciences Establishes New At-the-Market Facility
SAN DIEGO and TORONTO, March 28, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (APTO) (APS.TO), a clinical-stage company developing highly differentiated ...
March 28, 2018
Albireo to Present Clinical Data on A4250 at The International Liver Congress™ 2018
BOSTON, March 28, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
March 28, 2018
Arcturus Therapeutics Issues Open Letter to Shareholders
SAN DIEGO, March 28, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT), a leading RNA medicines company, today issued the following open letter to shareholders ...
March 28, 2018
CytoSorbents Reports on the Successful 5th International CytoSorb Users Meeting and 38th ISICEM Critical Care Conference
MONMOUTH JUNCTION, N.J., March 28, 2018 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using blood purification to treat deadly inflammation in critically-ill and ...
March 28, 2018
OSE Immunotherapeutics: 2017 Annual Results and Clinical Advances of its Proprietary and Partnered Products
NANTES, France, March 28, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN:FR0012127173) (Mnémo:OSE) today reports its consolidated annual financial results as of December 31, 2017 ...
March 28, 2018
Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017
VANCOUVER, March 28, 2018 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral ...
March 28, 2018
Heron Therapeutics Announces Proposed Public Offering of Common Stock
SAN DIEGO--(BUSINESS WIRE)--Heron Therapeutics, Inc. (HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of ...
March 28, 2018
Molecular Templates, Inc. Reports Fourth Quarter 2017 Financial Results
AUSTIN, Texas, March 28, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (MTEM) (“Molecular”), a clinical-stage oncology company focused on the discovery and development of the company’s ...
March 28, 2018
Altimmune Announces Financial Results for the Year Ended December 31, 2017 and Provides Corporate Update
GAITHERSBURG, Md., March 28, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced financial results for the year ended December 31, ...
March 27, 2018
Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares
SAN DIEGO, March 26, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced the completion of its previously announced underwritten public offering of 9,775,000 shares of its ...
March 27, 2018
Galmed Pharmaceuticals to Present New Scientific Data on the Mechanism by Which Aramchol Exerts its Effect on Fibrosis at EASL
TEL AVIV, Israel, March 27, 2018 /PRNewswire/ --Galmed Pharmaceuticals Ltd. (GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the ...
March 27, 2018
BioTime Announces Cash Sale of Ascendance Biotechnology
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that IVT Holdings acquired Ascendance Biotechnology, Inc. BioTime’s ...
Page 54 of 117